Jazz rolls the dice on a billion-dollar gamble on a new drug for SCLC — shooting for a 2020 launch
Two days after filing their cancer drug lurbinectedin in the hunt for an FDA approval, Spain’s PharmaMar has snagged $200 million in cash as a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
